Read how a Yale Medicine team, including John Elefteriades, MD, a heart surgeon and director of the Yale Center for Advanced Thoracic Aortic Disease at Yale New Haven Hospital’s Aortic Institute helped get Robert Palmer back to his life (and into his race car) again.
- May 30, 2018
The Department of Surgery, Section of Cardiac Surgery at Yale University received the highest Composite Quality Rating by the Society of Thoracic Surgeons (STS) National Database in four of five procedure categories: isolated aortic valve replacement (AVR); combined AVR and coronary artery bypass graft (CABG); mitral valve repair and replacement (MVRR); and combined MVRR and CABG.
- November 13, 2017
Arnar Geirsson, MD, who has pioneered several minimally invasive and robotic cardiac surgical procedures at Yale, has accepted the position of chief of the Section of Cardiac Surgery at Yale School of Medicine.
- August 04, 2017
Using nanoparticles, Yale researchers have developed a drug-delivery system that could reduce organ transplant complications by hiding the donated tissue from the recipient’s immune system.
- May 03, 2017
Connecticut Magazine’s 2017 “Top Docs” list includes 67 Yale Medicine physicians, who were selected based on a survey of their peers.
- August 25, 2016
In 2015, Yale researchers developed a strategy for detecting silent but deadly aortic aneurysms — areas of enlargement in arteries — that appear to run in families.
- April 01, 2016
Connecticut Magazine’s 2016 Top Doctors listing includes 60 Yale Medical Group physicians.
- February 14, 2016Source: NBC Connecticut
A Bridgeport man waiting for a heart transplant received a special gift from a donor and Yale-New Haven Hospital this Valentine’s Day.
- November 10, 2015
The YCCI November 2015 Newsletter - Education Edition is available online. Read about YCCI supporting the Venture Creation Consultant (VCC) program, a valuable resource offered through the Yale Entrepreneurial Institute (YEI) that provides specialized expertise for advancing new Yale ventures.
- July 16, 2015
Researchers at the Aortic Institute at Yale have tested the genomes of more than 100 patients with thoracic aortic aneurysms, a potentially lethal condition, and provided genetically personalized care. Their work will also lead to the development of a “dictionary” of genes specific to the disease, according to researchers.